Commercial Cell and Gene Therapy Revenue -- $9.1 million, up 26% year over year, reflecting growth in therapies supported.

The findings, which led to a provisional patent filing, suggest Converge Bio improved cetuximab bindings to the receptor, achieving 2x higher affinity using a single AI prompt, strengthening its ...

Yet, in an ironic twist of fate, it's the individual's critical thinking skills and cognitive clarity that AI tooling has now ...

Cruising the Loire River is not like cruising the Rhine or Danube—and that’s exactly the point. The pace is slower, the ...